Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Clegg

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Plos Medicine|April 7, 2025
Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse eventsHeather Wightman, Elaine Butterly, Lili Wei, et al.
Health and Social Care Delivery Research|November 2, 2024
Impact of frailty in older people on health care demand: simulation modelling of population dynamics to inform service planningBronagh Walsh, Carole Fogg, Tracey England, et al.
Age and Ageing|August 19, 2024
Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registryRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
Age and Ageing|March 31, 2025
Development and external validation of the electronic frailty index 2 using routine primary care electronic health record dataKate Best, Farag Shuweihdi, Juan Carlos Bazo Alvarez, et al.
Trials|January 3, 2024
PeRsOnaliSed care Planning for oldER people with frailty (PROSPER): protocol for a randomised controlled trialAnne Heaven, Peter Bower, Florence Day, et al.
Health Technology Assessment (Winchester, England)|January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Health Technology Assessment (Winchester, England)|March 7, 2018
Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Applied Health Economics and Health Policy|July 9, 2025
Funding Health Promotion Activities to Reduce Avoidable Hospital Admissions in Frail Older Adults (HomeHealth): Further Challenges to the "Cost-Effective but Unaffordable" ParadoxRachael Maree Hunter, Rachael Frost, Sarah Kalwarowsky, et al.
Pilot and Feasibility Studies|May 2, 2020
Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18Anne Heaven, Peter Bower, Bonnie Cundill, et al.
Trials|February 6, 2014
Pilot trial of Stop Delirium! (PiTStop)--a complex intervention to prevent delirium in care homes for older people: study protocol for a cluster randomised controlled trialAnne Heaven, Francine Cheater, Andrew Clegg, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Plos Medicine|April 7, 2025
Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse eventsHeather Wightman, Elaine Butterly, Lili Wei, et al.
Health and Social Care Delivery Research|November 2, 2024
Impact of frailty in older people on health care demand: simulation modelling of population dynamics to inform service planningBronagh Walsh, Carole Fogg, Tracey England, et al.
Age and Ageing|August 19, 2024
Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registryRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
Age and Ageing|March 31, 2025
Development and external validation of the electronic frailty index 2 using routine primary care electronic health record dataKate Best, Farag Shuweihdi, Juan Carlos Bazo Alvarez, et al.
Trials|January 3, 2024
PeRsOnaliSed care Planning for oldER people with frailty (PROSPER): protocol for a randomised controlled trialAnne Heaven, Peter Bower, Florence Day, et al.
Health Technology Assessment (Winchester, England)|January 21, 2017
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Health Technology Assessment (Winchester, England)|March 7, 2018
Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluationRhona Johnston, Olalekan Uthman, Ewen Cummins, et al.
Applied Health Economics and Health Policy|July 9, 2025
Funding Health Promotion Activities to Reduce Avoidable Hospital Admissions in Frail Older Adults (HomeHealth): Further Challenges to the "Cost-Effective but Unaffordable" ParadoxRachael Maree Hunter, Rachael Frost, Sarah Kalwarowsky, et al.
Pilot and Feasibility Studies|May 2, 2020
Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18Anne Heaven, Peter Bower, Bonnie Cundill, et al.
Trials|February 6, 2014
Pilot trial of Stop Delirium! (PiTStop)--a complex intervention to prevent delirium in care homes for older people: study protocol for a cluster randomised controlled trialAnne Heaven, Francine Cheater, Andrew Clegg, et al.
Pageof 21